Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Termination of Nucleos(t)Ide Analogue Therapy of HBeAg Negative Chronic Hepatitis B - 2nd Register Study

NCT03643172 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT03643172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03643172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Termination of Nucleos(t)Ide Analogue Therapy of HBeAg Negative Chronic Hepatitis B - 2nd Register Study
Lead sponsor
Hannover Medical School
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2018
Completion date
July 31, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, hbeag negative